Business Insider3y
Arch, one of biotechs biggest investors, uses anger as an investment strategy. A top VC there explains what she's focused on now.
But the investors at Arch Venture Partners are instead driven by frustration. Cofounder Robert Nelsen told reporters he was upset when hearing about shortages of COVID-19 treatments, surgical ...